Bladder cancer: Present and future

被引：144

作者：

Martinez Rodriguez, Roberto Hugo ^{[1
]}

Buisan Rueda, Oscar ^{[1
]}

Ibarz, Luis ^{[1
]}

机构：

[1] Hosp Badalona Germans Trias & Pujol, Serv Urol, Barcelona, Spain

来源：

MEDICINA CLINICA | 2017年 / 149卷 / 10期

关键词：

Bladder cancer; Urothelial; Calmette-Guerin bacillus; Immunotherapy; Haematuria; Cystectomy; BACILLUS-CALMETTE-GUERIN; RESTAGING TRANSURETHRAL RESECTION; RADICAL CYSTECTOMY; UROTHELIAL CARCINOMA; NEOADJUVANT CHEMOTHERAPY; LUMINAL SUBTYPES; CELL-CARCINOMA; IMMUNOTHERAPY; THERAPY; IMMEDIATE;

D O I：

10.1016/j.medcli.2017.06.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bladder cancer has a high incidence and involves high associated morbidity and mortality. Since its initial clinical suspicion, early diagnostic confirmation and multimodal treatment involve different medical specialties. For this reason, we consider it important to spread the current consensus for its management. Recent advances in immunology and Chemotherapy make it necessary to expose and reflect on future perspectives. (C) 2017 Elsevier Espana, S.L.U. All rights reserved.

引用

页码：449 / 455

页数：7

共 42 条

[1] Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: A paradigm for molecular subtyping of urothelial cell carcinoma of the bladder [J].

Adam, Rosalyn M. ;

DeGraff, David J. .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (10) :444-450

[2] Prognostic factors in stage T1 bladder cancer:: Tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion [J].

Andius, Patrik ;

Johansson, Sonny L. ;

Holmaeng, Sten .

UROLOGY, 2007, 70 (04) :758-762

[3]

[Anonymous], COCHRANE DATABASE SY

[4] Reactive Antibodies Against Bacillus Calmette-Guerin Heat-Shock Protein-65 Potentially Predict the Outcome of Immunotherapy for High-Grade Transitional Cell Carcinoma of the Bladder [J].

Ardelt, Peter U. ;

Kneitz, Burkhard ;

Adam, Patrick ;

Reiss, Cora ;

Kocot, Arkadius ;

Fensterle, Joachim ;

Chen, Limor ;

Pasqualini, Renata ;

Arap, Wadih ;

Gerharz, Elmar W. ;

Riedmiller, Hubertus .

CANCER, 2010, 116 (03) :600-609

[5] Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma [J].

Bellmunt, J. ;

Mullane, S. A. ;

Werner, L. ;

Fay, A. P. ;

Callea, M. ;

Leow, J. J. ;

Taplin, M. E. ;

Choueiri, T. K. ;

Hodi, F. S. ;

Freeman, G. J. ;

Signoretti, S. .

ANNALS OF ONCOLOGY, 2015, 26 (04) :812-817

[6] A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now [J].

Bellmunt, Joaquin ;

Powles, Thomas ;

Vogelzang, Nicholas J. .

CANCER TREATMENT REVIEWS, 2017, 54 :58-67

[7] Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer [J].

Buisan, Oscar ;

Orsola, Anna ;

Areal, Joan ;

Font, Albert ;

Oliveira, Mario ;

Martinez, Roberto ;

Ibarz, Luis .

CLINICAL GENITOURINARY CANCER, 2017, 15 (01) :145-151

[8]

Casans-Francés R, 2017, REV ESP ANEST REANIM, V64, P313, DOI [10.1016/j.redar.2016.12.002, 10.1016/j.redare.2016.12.005]

[9] Predicting extravesical extension of bladder carcinoma: A novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens [J].

Cheng, L ;

Weaver, AL ;

Bostwick, DG .

UROLOGY, 2000, 55 (05) :668-672

[10] Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer [J].

Choi, Woonyoung ;

Czemiak, Bogdan ;

Ochoa, Andrea ;

Su, Xiaoping ;

Siefker-Radtke, Arlene ;

Dinney, Colin ;

McConkey, David J. .

NATURE REVIEWS UROLOGY, 2014, 11 (07) :400-410

← 1 2 3 4 5 →